Cancer stem-like cell: A novel target for nasopharyngeal carcinoma therapy

45Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nasopharyngeal carcinoma (NPC) is the most common cancer originating in the nasopharynx, and is extremely common in southern regions of China. Although the standard combination of radiotherapy and chemotherapy has improved the efficiency in patients with NPC, relapse and early metastasis are still the common causes of mortality. Cancer stem-like cells (CSCs) or tumor initial cells are hypothesized to be involved in cancer metastasis and recurrence. Over the past decade, increasing numbers of studies have been carried out to identify CSCs from human NPC cells and tissues. The present paper will summarize the investigations on nasopharyngeal CSCs, including isolation, characteristics, and therapeutic approaches. Although there are still numerous challenges to translate basic research into clinical applications, understanding the molecular details of CSCs is essential for developing effective strategies to prevent the recurrence and metastasis of NPC. © 2014 Wei et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Wei, P., Niu, M., Pan, S., Zhou, Y., Shuai, C., Wang, J., … Li, G. (2014, March 27). Cancer stem-like cell: A novel target for nasopharyngeal carcinoma therapy. Stem Cell Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/scrt433

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free